Reduced CD127 expression in peripheral Ets-1 deficient T cells

Reduced CD127 expression in peripheral Ets-1 deficient T cells. as a critical regulator of CD127 expression in T cells. == Introduction == IL-7 signals are required for T cell development, maintaining the nave T cell pool, mounting proper primary responses, and inducing and maintaining CD4+and CD8+T cell SB-224289 hydrochloride memory (13). The IL-7 receptor consists of the IL-7R chain (CD127), which binds IL-7, and the common gamma chain (c, CD132). CD127 expression is usually dynamically regulated throughout T cell development, activation, and memory formation (2,4). Many extracellular stimuli can modulate the expression of CD127. For example, TCR signals (5), IL-7 (6), and the HIV Tat protein (7) have been shown to inhibit the expression of CD127. However, the mechanisms governing this dynamic regulation of CD127 are poorly comprehended. The constitutive expression of CD127 is regulated by members of the Ets family of transcription factors in different lymphoid lineages. Ets proteins are characterized by their DNA-binding Ets domain name (8). The B cell-specific PU.1 is essential for the expression of CD127 in SB-224289 hydrochloride linhematopoietic progenitors and pro-B cells (9), whereas GABP is required for the expression of CD127 in early thymocytes (10). Both factors bind to a functionally crucial Ets binding site in the CD127 promoter. But whether GABP or another Ets protein is responsible for maintaining CD127 expression in SB-224289 hydrochloride peripheral T cells is usually unknown. Ets-1 (E26 transformation-specific sequence) is the founding member of the Ets family of transcription factors and is expressed at high levels in lymphoid cells (8,11). Ets-1 has been shown to promote Th1 and inhibit Th17 differentiation (12,13). Ets-1 is also recruited to the IL-5/IL-13/IL-4 locus and required for the optimal expression of these cytokines (14). T cells express two splice variants, the full-length Ets-1 p51 and the shorter Ets-1 p42 that lacks ExonVII (15,16). The activity of Ets-1 is usually regulated by activating and inactivating phosphorylation events (11), but the role of these phosphorylation events in regulating the function of Th cells remains controversial (17). Here we show that Ets-1 directly binds to and activates the CD127 promoter. Ets-1-deficient (KO) T cells expressed reduced levels of CD127 and displayed impaired IL-7-dependent survival and homeostatic proliferation. Importantly, the level of CD127 in human T cells strongly correlates with that of Ets-1. Loss of CD127 expression is usually a hallmark of CD8+T cells during chronic viral contamination (18,19). The expression of Ets-1 is also reduced in CD8+T cells of HIV-positive individuals mainly due to an growth of effector/effector memory cells. Interestingly, HIV-associated reduction in CD127 occurs only in Ets-1loweffector memory and central memory Tmem2 cells but not in Ets-1highnave cells. Thus, our data demonstrate that Ets-1 is usually a SB-224289 hydrochloride critical regulator of CD127 in peripheral T cells. == Material and methods == == Study subjects == The study included 10 individuals chronically infected with HIV. Four of these subjects were treated with antiviral therapy (ARV) and six were untreated. All but one experienced plasma viral loads above the limit of detection of the quantitative assays utilized for clinical monitoring (>50 or >75 viral mRNA copies/mL). Median viral weight was 21,200 viral mRNA copies/mL (range: <75 to 233,000). Additionally, ten HIV-uninfected healthy volunteers were included as controls. Human subject protocols were approved by all participating hospitals and clinics, and all subjects provided written informed consent prior to enrollment. == Mice == Ets-1 deficient mice were explained previously (20). Mice were backcrossed to the C57BL/6 background for six generations and managed by mating Ets-1/male to Ets-1+/female mice. Ets-1+/(designated HET) and Ets-1/(designated KO) littermates were used throughout the studies. Congenic CD45.1 C57BL/6 and CD45.1 Rag2/mice were purchased from Taconic (Hudson, NY). The animals were housed under specific pathogen free conditions, and all experiments were carried out in accordance with the institutional guidelines for animal care at the Dana-Farber Malignancy Institute. == Cell lysates, SB-224289 hydrochloride Western Blot, and Antibodies == Total cell lysates, nuclear or cytosolic extracts were adjusted for total protein content and subjected to SDS-PAGE followed by Western Blot. The following antibodies were used: anti-STAT5 and anti-Phospho-STAT5 (Tyr694) (Cell Signaling Technology, Danvers, MA), and anti-Hsp90 (both Santa Cruz Biotechnology, Santa Cruz, CA). As secondary antibodies, HRP-coupled goat-anti-rabbit IgG was.